Weighted Average Number of Shares Outstanding, Diluted of Apyx Medical Corp from 31 Dec 2010 to 30 Jun 2024

Taxonomy & unit: us-gaap: shares
Description: The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary: Apyx Medical Corp quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2010 to 30 Jun 2024.
Apyx Medical Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 34,644,000, a 0.12% increase year-over-year.
Apyx Medical Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 34,622,000, a 0.31% increase from 2022.
Apyx Medical Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 34,516,000, a 0.54% increase from 2021.
Apyx Medical Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 34,332,000, a 0.35% increase from 2020.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Apyx Medical Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024	34,644,000	+41,000	+0.12%	01 Apr 2024	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	34,644,000	+46,000	+0.13%	01 Jan 2024	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	34,622,000	+106,000	+0.31%	01 Oct 2023	31 Dec 2023	10-K	21 Mar 2024	2023	FY
Q3 2023	34,642,000	+73,000	+0.21%	01 Jul 2023	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	34,603,000	+139,000	+0.4%	01 Apr 2023	30 Jun 2023	10-Q	08 Aug 2024	2024	Q2
Q1 2023	34,598,000	+169,000	+0.49%	01 Jan 2023	31 Mar 2023	10-Q	09 May 2024	2024	Q1
Q4 2022	34,516,000	+184,000	+0.54%	01 Oct 2022	31 Dec 2022	10-K	21 Mar 2024	2023	FY
Q3 2022	34,569,000	+239,000	+0.7%	01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2023	2023	Q3
Q2 2022	34,464,000	+143,000	+0.42%	01 Apr 2022	30 Jun 2022	10-Q	11 Aug 2023	2023	Q2
Q1 2022	34,429,000	+127,000	+0.37%	01 Jan 2022	31 Mar 2022	10-Q	11 May 2023	2023	Q1
Q4 2021	34,332,000			01 Oct 2021	31 Dec 2021	10-K	16 Mar 2023	2022	FY
Q3 2021	34,330,000	+114,000	+0.33%	01 Jul 2021	30 Sep 2021	10-Q	10 Nov 2022	2022	Q3
Q2 2021	34,321,000	+135,000	+0.4%	01 Apr 2021	30 Jun 2021	10-Q	11 Aug 2022	2022	Q2
Q1 2021	34,302,000			01 Jan 2021	31 Mar 2021	10-Q	12 May 2022	2022	Q1
Q3 2020	34,216,000			01 Jul 2020	30 Sep 2020	10-Q	12 Nov 2021	2021	Q3
Q2 2020	34,186,000			01 Apr 2020	30 Jun 2020	10-Q	12 Aug 2021	2021	Q2
Q4 2018	34,366,000	+2,939,000	+9.4%	01 Oct 2018	31 Dec 2018	10-K	31 Mar 2020	2019	FY
Q3 2018	34,934,000	+3,856,000	+12%	01 Jul 2018	30 Sep 2018	10-Q/A	08 May 2020	2018	Q3
Q2 2018	32,890,000	+2,030,000	+6.6%	01 Apr 2018	30 Jun 2018	10-Q	01 Aug 2018	2018	Q2
Q1 2018	32,878,000	+1,991,000	+6.4%	01 Jan 2018	31 Mar 2018	10-Q	15 May 2018	2018	Q1
Q4 2017	31,427,000	+3,978,000	+14%	01 Oct 2017	31 Dec 2017	10-K	31 Mar 2020	2019	FY
Q3 2017	31,078,000	+4,003,000	+15%	01 Jul 2017	30 Sep 2017	10-Q/A	08 May 2020	2018	Q3
Q2 2017	30,860,000	+3,809,000	+14%	01 Apr 2017	30 Jun 2017	10-Q	01 Aug 2018	2018	Q2
Q1 2017	30,887,000	+3,836,000	+14%	01 Jan 2017	31 Mar 2017	10-Q	15 May 2018	2018	Q1
Q4 2016	27,449,000	-298,000	-1.1%	01 Oct 2016	31 Dec 2016	10-K	14 Mar 2019	2018	FY
Q3 2016	27,075,000	+24,000	+0.09%	01 Jul 2016	30 Sep 2016	10-Q	03 Nov 2017	2017	Q3
Q2 2016	27,051,000	+27,026,565		01 Apr 2016	30 Jun 2016	10-Q	03 Aug 2017	2017	Q2
Q1 2016	27,051,000	+6,581,000	+32%	01 Jan 2016	31 Mar 2016	10-Q	15 May 2017	2017	Q1
Q4 2015	27,747,000	+9,991,000	+56%	01 Oct 2015	31 Dec 2015	10-K	13 Mar 2018	2017	FY
Q3 2015	27,051,000	+9,271,000	+52%	01 Jul 2015	30 Sep 2015	10-Q	27 Oct 2016	2016	Q3
Q2 2015	24,435^*	-21,151,565		01 Apr 2015	30 Jun 2015	10-Q	02 Aug 2016	2016	Q2
Q1 2015	20,470,000	+20,452,316		01 Jan 2015	31 Mar 2015	10-Q	11 May 2016	2016	Q1
Q4 2014	17,756,000	-4,000	-0.02%	01 Oct 2014	31 Dec 2014	10-K	10 Mar 2017	2016	FY
Q3 2014	17,780,000	+17,762,322		01 Jul 2014	30 Sep 2014	10-Q	05 Nov 2015	2015	Q3
Q2 2014	21,176,000	+21,158,331		01 Apr 2014	30 Jun 2014	10-Q	07 Aug 2015	2015	Q2
Q1 2014	17,684^*	+34		01 Jan 2014	31 Mar 2014	10-Q	08 May 2015	2015	Q1
Q4 2013	17,760,000			01 Oct 2013	31 Dec 2013	10-K	18 Mar 2016	2015	FY
Q3 2013	17,678^*	+44		01 Jul 2013	30 Sep 2013	10-Q	10 Nov 2014	2014	Q3
Q2 2013	17,669^*	-99		01 Apr 2013	30 Jun 2013	10-Q	08 Aug 2014	2014	Q2
Q1 2013	17,650^*	-17,773,350		01 Jan 2013	31 Mar 2013	10-Q	15 May 2014	2014	Q1
Q3 2012	17,634^*	-17,756,366		01 Jul 2012	30 Sep 2012	10-Q	14 Nov 2013	2013	Q3
Q2 2012	17,768^*	-17,809,232		01 Apr 2012	30 Jun 2012	10-Q/A	25 Sep 2013	2013	Q2
Q1 2012	17,791,000			01 Jan 2012	31 Mar 2012	10-Q	15 May 2013	2013	Q1
Q3 2011	17,774,000			01 Jul 2011	30 Sep 2011	10-Q	14 Nov 2012	2012	Q3
Q2 2011	17,827,000			01 Apr 2011	30 Jun 2011	10-Q	14 Aug 2012	2012	Q2

Apyx Medical Corp Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	34,622,000	+106,000	+0.31%	01 Jan 2023	31 Dec 2023	10-K	21 Mar 2024	2023	FY
2022	34,516,000	+184,000	+0.54%	01 Jan 2022	31 Dec 2022	10-K	21 Mar 2024	2023	FY
2021	34,332,000	+120,000	+0.35%	01 Jan 2021	31 Dec 2021	10-K	16 Mar 2023	2022	FY
2020	34,212,000	+143,000	+0.42%	01 Jan 2020	31 Dec 2020	10-K	17 Mar 2022	2021	FY
2019	34,069,000	-297,000	-0.86%	01 Jan 2019	31 Dec 2019	10-K	31 Mar 2020	2019	FY
2018	34,366,000	+2,939,000	+9.4%	01 Jan 2018	31 Dec 2018	10-K	31 Mar 2020	2019	FY
2017	31,427,000	+3,978,000	+14%	01 Jan 2017	31 Dec 2017	10-K	31 Mar 2020	2019	FY
2016	27,449,000	-298,000	-1.1%	01 Jan 2016	31 Dec 2016	10-K	14 Mar 2019	2018	FY
2015	27,747,000	+9,991,000	+56%	01 Jan 2015	31 Dec 2015	10-K	13 Mar 2018	2017	FY
2014	17,756,000	-4,000	-0.02%	01 Jan 2014	31 Dec 2014	10-K	10 Mar 2017	2016	FY
2013	17,760,000	+17,742,213		01 Jan 2013	31 Dec 2013	10-K	18 Mar 2016	2015	FY
2012	17,787^*	+118		01 Jan 2012	31 Dec 2012	10-K	27 Feb 2015	2014	FY
2011	17,669^*	-17,349,331		01 Jan 2011	31 Dec 2011	10-K/A	08 May 2014	2013	FY
2010	17,367,000			01 Jan 2010	31 Dec 2010	10-K	01 Apr 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.